Euroapi S.A.S.U. (EAPI)
Euronext
Closed
Oct 9, 2026
Day's Range
0.736052 wk Range
0.7130Overview - EAPI - Euroapi S.A.S.U.
Key Statistics
Valuation
Enterprise Value
130.07M
P/E (Trailing)
‪8.84‬
P/E (Forward)
‪-3.41‬
PEG Ratio
‪-3.41‬
Price / Sales (TTM)
‪0.08‬
Price / Book
‪0.14‬
EV / EBITDA
‪0.98‬
Profitability
Profit Margin
‪-40.80%‬
Operating Margin
‪-2.86%‬
Return on Assets
‪-0.93%‬
Return on Equity
‪-39.99%‬
Ownership
Shares Outstanding
95.18M
Float
50.79M
Held by Insiders
‪34.83%‬
Held by Institutions
‪36.01%‬
Price stats
Beta
‪0.95‬
50-Day Avg
‪0.9834‬
200-Day Avg
‪1.48‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪€ 1.15‬Market Cap - EAPI - Euroapi S.A.S.U.
Peers - EAPI - Euroapi S.A.S.U.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.
Profile Summary - EAPI - Euroapi S.A.S.U.
About
Euroapi S.A.S.U. is a leading pharmaceutical company specializing in the development, manufacturing, marketing, and distribution of active pharmaceutical ingredients (APIs) and intermediates for human and veterinary medicines. With approximately 200 products in its portfolio, it offers one of the largest selections in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
